Analysts' Actions: ATHN CIT FB FFIV RHT

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

AthenaHealth downgraded at Leerink Swann to market perform from outperform. $120 price target. Bookings growth rate is slowing, Leerink Swann said.

Armstrong World Industries was upgraded to buy at TheStreet Ratings.

Sotheby's was upgraded at Citigroup to buy from neutral. Management is pursuing multiple ways to create shareholder value, said Citigroup. Price target was raised to $55.

CIT Group was upgraded at Jefferies to buy from hold. $65 price target. Well positioned for book value and multiple expansion, Jefferies said.

Diamondback Energy was upgraded at Sterne Agee to buy. $54 price target. Mineral Rights purchase should add to earnings, Sterne Agee said.

Facebook was upgraded at Citigroup to buy from neutral. Advertiser checks reveal sustainable growth drivers, said Citigroup. Price target raised to $55.

F5 Networks was downgraded at Goldman Sachs to neutral from buy. $93 price target. See limited upside potential to expectations, Goldman said.

HanesBrands was downgraded at DA Davidson to neutral from buy. $68 price target. Valuation call, as the stock is up 75% year to date, DA Davidson said.

Hologic was upgraded at ISI Group to strong buy from buy. $25.50 price target. Company will likely cut costs and may shed noncore assets, ISI Group.

Quintiles was initiated with an outperform rating at Credit Suisse. Valuation call, based on a $52 price target.

Red Hat was downgraded at Pacific Crest to sector perform. Company is seeing lower demand in Europe and seeing big deals pushed out, Pacific Crest said.

Red Hat was downgraded at Piper Jaffray to neutral from overweight. $50 price target. Company lacks sales catalysts, Piper Jaffray said.

Rovi was upgraded at B. Riley to buy from neutral. $25.50 price target. Stock has pulled back 30% over the past three months, B. Riley said.

Thermon Group was upgraded to buy at TheStreet Ratings.

Hanover Insurance was upgraded at JMP Securities to outperform from market perform. $61 price target. Estimates also upped, given strong pricing trends, JMP Securities said.

Webster Financial was upgraded at Sterne Agee to buy from neutral. $28 price target. Stock has lagged and the company has room to cut costs, Sterne Agee said.

STOCK COMMENTS / EPS CHANGES

Apple estimates, price target were increased at Goldman Sachs. Estimates were boosted through 2014. Company is seeing higher demand for the new iPhone, Goldman said. Buy rating and new $560 price target.

Amgen price target was boosted at BMO Capital. Shares are now seen reaching $116. Pipeline prospects continue to improve, BMO Capital said. Market Perform rating.

Macy's estimates, price target were reduced at Sterne Agee. Estimates were cut through 2014. Mall traffic remains weak, Sterne Agee said. Buy rating and new $52 price target.

MGM Resorts numbers were increased at Cantor Fitzgerald. Estimates were boosted through 2014. Macau and Las Vegas remain strong, Cantor said. Buy rating and new $23 price target.

Nike price target was raised at Bank of America/Merrill Lynch. Shares are now seen reaching $75. See potential upside to futures orders, BofA/Merrill said. Buy rating.

Northern Tier Energy numbers were reduced at UBS. Earnings estimates were cut due to the recent fire at the St. Paul refinery, said UBS. Price target reduced to $28.

Superior Energy numbers were cut at Credit Suisse. Shares are now seen reaching $33. Estimates were also reduced. Service activity continues to lag expectations, Credit Suisse said. Outperform rating.

Triumph numbers were reduced at UBS. Earnings estimates were cut to reflect lower margins on 747-8 and the wind-down of the C-17 program, said UBS. Price target reduced to $85.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

Rates

View Comments (0)